In addition, Kornspan et al. found that overexpression of TLE3 but not TLE1 enhanced non-small cell lung cancer (NSCLC) cell line sensitivity to taxane treatment (Kornspan et al., 2021). The gene discussed is TLE1; the disease is non-small cell lung carcinoma.